Advertisement
Advertisement
Skip to content
Follow Us on
Advertisement
TOP STORIES
DGFT

Amendment in Export Policy of Hydroxychloroquine API & its Formulations

Advertisement

The Notification No. 54 dated 25.03.2020 has been amended to change the export policy of Hydroxychloroquine API and its formulations from ‘Prohibited’ to ‘Free’, with immediate effect.

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi

Notification No. 13/2015-2020

New Delhi, Dated: 18th June, 2020

Subject: – Amendment in Export Policy of Hydroxychloroquine API and its Formulations.

S.O. 1963(E).- In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendments in the Notification No. 54 dated 25.03.2020 amending the Schedule 2 of the ITCHS Export Policy related to export of Hydroxychloroquine and its formulations, with immediate effect:

S.No ITC HS Codes Description Present Policy Revised Policy
207 F 29334900

29333990

29339900

Hydroxychloroquine Prohibited Free
207 F 30049059

30049099

Formulations made from Hydroxychloroquine Prohibited Free

Effect of this Notification:

The Notification No. 54 dated 25.03.2020 has been amended to change the export policy of Hydroxychloroquine API and its formulations from “Prohibited” to “Free”, with immediate effect.

(Arnit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: [email protected]

(Issued from file No. 01/91/180/21 /AM20/EC/E-21154)

Advertisement

Join TaxGuru's Network for the latest updates on Income Tax, GST, Company Law, Corporate Laws and other related subjects.

Leave a Reply

Your email address will not be published. Required fields are marked *